Why the study?
Does macrophage depletion with clodronate liposomes reduce neointimal hyperplasia and IL-18 accumulation after vascular injury in aged rats?
Population
Aged male Fisher rats (21- to 23-mo-old, F344) and young male Fisher rats (2-4 mo-old)
Comparison
Balloon injury in the right iliac artery… vs Young rats; control liposomes
Design
Preclinical, Investigator blinded to the experimental group for morphometric…
Follow-up
Up to 30 days
Key result
Aging significantly increased neointimal hyperplasia after vascular injury (N/NM ratio 0.8 vs 0.54, p=0.008), driven by macrophage-derived IL-18 and fibrinogen deposition.
Authors
Loading...
Aging heightens post-injury neointimal hyperplasia via macrophage IL-18 in rats; leaves open targeted inhibition for clinical restenosis prevention.
Does macrophage depletion with clodronate liposomes reduce neointimal hyperplasia and IL-18 accumulation after vascular injury in aged rats?
Absolute Event Rate: 0.8% vs 0.54%
p-value: p=0.008
Aging exacerbates post-injury neointimal hyperplasia through a local inflammatory response driven by macrophage-derived IL-18, which inhibits VSMC apoptosis and promotes further inflammation.
Rodriguez-Menocal et al. (2014) studied Vascular injury and neointimal hyperplasia. Aging vs. Young rats was evaluated on Neointima to neointima-media thickness ratio (N/NM ratio) at day 30 (p=0.008). Aging significantly increased neointimal hyperplasia after vascular injury (N/NM ratio 0.8 vs 0.54, p=0.008), driven by macrophage-derived IL-18 and fibrinogen deposition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: